AnalysisBusinessNovember 16, 2026

Flagship's Afeyan sees UK bet creating next Moderna

Read original source →bloomberg.com

Flagship Pioneering founder Noubar Afeyan says the firm hopes its new UK investment can grow to as much as £600 million "relatively soon," its first full-scale company-creation operation outside the US. He also discussed how AI could accelerate drug discovery and why autonomous AI agents need agreed safeguards.

People · Noubar Afeyan

1 source

More stories today

Open the live feed